We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Indian Diagnostic Company Transasia Bio-Medical Acquires Pliva Lachema Diagnostica

By LabMedica International staff writers
Posted on 20 Oct 2009
An Indian clinical diagnostics company, Transasia Bio-Medicals Ltd. More...
(Mumbai, India) has acquired Pliva Lachema Diagnostika (Brno, Czech Republic). The acquisition will bring advanced technology within reach for India's vast population.

The acquisition provides an opportunity for Transasia and ERBA to introduce newer products to the swiftly developing markets of Asia. Transasia and its 100% German subsidiary, ERBA Diagnostics Mannheim GmbH (Germany) have a team of experienced marketing and service professionals and a large distribution network. It markets products in countries, which include Italy, Germany, France, China, Turkey, Russia, and around the globe.

PLIVA Lachema Diagnostika develops, produces, and markets in vitro diagnostics (IVD) products for urine analysis, biochemistry, and microbiology. The company has an extensive marketing and distribution network in the countries of Central and Eastern Europe, which will complement the current market potential and product lines of Transasia and ERBA Mannheim

Lachema's customers in Central and Eastern Europe will have access to Transasia's large product range in clinical chemistry, immunoturbidimetry, and immunology. Transasia Bio-Medicals Ltd. and ERBA Diagnostics Mannheim intend to invest more than US$1 million in Lachema to increase its manufacturing capacities and add new quality, affordable, wide spectrum products in the near future.

Related Links:
Transasia Bio-Medicals Ltd.
Pliva Lachema Diagnostika



New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
New
Pan-Cancer Panel
TruSight Oncology 500
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.